Sclafani M, Falasconi G, Tini G, Musumeci B, Penela D, Saglietto A
J Clin Med. 2025; 14(4).
PMID: 40004861
PMC: 11857077.
DOI: 10.3390/jcm14041331.
Musumeci B, Tini G, Russo D, Sclafani M, Cava F, Tropea A
J Clin Med. 2021; 10(8).
PMID: 33916967
PMC: 8067545.
DOI: 10.3390/jcm10081547.
Autore C, Musumeci M
Eur Heart J Suppl. 2021; 22(Suppl L):L11-L14.
PMID: 33654461
PMC: 7904071.
DOI: 10.1093/eurheartj/suaa125.
Songsirisuk N, Kittipibul V, Methachittiphan N, Charoenattasil V, Zungsontiporn N, Spanuchart I
BMC Cardiovasc Disord. 2019; 19(1):1.
PMID: 30606129
PMC: 6318850.
DOI: 10.1186/s12872-018-0984-0.
Bajwa S, Bajwa S, Sood A
Anesth Essays Res. 2015; 4(2):115-8.
PMID: 25885243
PMC: 4173346.
DOI: 10.4103/0259-1162.73520.
Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment.
van der Lee C, Kofflard M, Geleijnse M, Ten Cate F
Neth Heart J. 2015; 13(12):452-460.
PMID: 25696443
PMC: 2497370.
Pregnancy-induced severe left ventricular systolic dysfunction in a patient with hypertrophic cardiomyopathy.
Kazimuddin M, Vashist A, Basher A, Brown Jr E, Alhaddad I
Clin Cardiol. 1998; 21(11):848-50.
PMID: 9825201
PMC: 6656090.
DOI: 10.1002/clc.4960211114.
Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron B
Heart. 1998; 79(4):331-6.
PMID: 9616338
PMC: 1728662.
DOI: 10.1136/hrt.79.4.331.
Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.
Landmark K, Sire S, Thaulow E, Amlie J, NITTER-HAUGE S
Br Heart J. 1982; 48(1):19-26.
PMID: 7200796
PMC: 481196.
DOI: 10.1136/hrt.48.1.19.
Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways.
Krikler D, Davies M, Rowland E, Goodwin J, Evans R, Shaw D
Br Heart J. 1980; 43(3):245-51.
PMID: 7192150
PMC: 482272.
DOI: 10.1136/hrt.43.3.245.
Hypertrophic cardiomyopathy presenting before 2 years of age in 13 patients.
Schaffer M, Freedom R, Rowe R
Pediatr Cardiol. 1983; 4(2):113-9.
PMID: 6683838
DOI: 10.1007/BF02076335.
Relation between left ventricular gradient and relative stroke volume ejected in early and late systole in hypertrophic cardiomyopathy. Assessment with radionuclide cineangiography.
Sugrue D, McKenna W, Dickie S, Myers M, LAVENDER J, Oakley C
Br Heart J. 1984; 52(6):602-9.
PMID: 6542420
PMC: 481691.
DOI: 10.1136/hrt.52.6.602.
Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs.
Alvares R, Goodwin J
Br Heart J. 1982; 48(3):204-12.
PMID: 6125160
PMC: 481230.
DOI: 10.1136/hrt.48.3.204.
The frontiers of cardiomyopathy.
Goodwin J
Br Heart J. 1982; 48(1):1-18.
PMID: 6123334
PMC: 481195.
DOI: 10.1136/hrt.48.1.1.
Idiopathic hypertrophic obstructive cardiomyopathy causing severe right ventricular outflow tract obstruction in infancy.
Barr P, Celermajer J, BOWDLER J, CARTMILL T
Br Heart J. 1973; 35(11):1109-15.
PMID: 4796863
PMC: 458764.
DOI: 10.1136/hrt.35.11.1109.
The cardiomyopathies.
Goodwin J, Oakley C
Br Heart J. 1972; 34(6):545-52.
PMID: 4402697
PMC: 458499.
DOI: 10.1136/hrt.34.6.545.
Twin studies in hypertrophic cardiomyopathy.
Littler W
Br Heart J. 1972; 34(11):1147-51.
PMID: 4264084
PMC: 487045.
DOI: 10.1136/hrt.34.11.1147.
Panel discussion: the treatment of hypertrophic cardiomyopathy with beta-adrenergic blockade.
Postgrad Med J. 1972; 48(566):791-5.
PMID: 4146124
PMC: 2495427.
DOI: 10.1136/pgmj.48.566.791.
Hypertrophic cardiomyopathy simulating an infiltrative myocardial disease.
Frustaci A, Loperfido F, Pennestri F
Br Heart J. 1985; 54(3):329-32.
PMID: 4041302
PMC: 481904.
DOI: 10.1136/hrt.54.3.329.
Hypertrophic cardiomyopathy, ten years' experience.
Kenny J, McCarthy C, Blake S, McCann P, COUNIHAN T
Ir J Med Sci. 1987; 156(2):56-60.
PMID: 3570701
DOI: 10.1007/BF02976420.